News Press Releases Genenta to Provide Update on Lead Product Temferon™ May 16, 2023 Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing Apr 26, 2023 Genenta Announces Extension of License Agreement with Ospedale San Raffaele to All Solid Tumor Indications Apr 03, 2023 Learn More Upcoming Events EACR 2023 Congress, the Annual Congress of the European Association for Cancer Research Jun 14, 2023 Location Torino, Italy Maxim Group’s Virtual Healthcare Conference Jun 20 - Jun 21, 2023 POLIMI – Graduate School of Management live event “Paving the Way for a better Future: investing, nurturing, and growing Biotech and Sustainable companies Jun 22, 2023 Molecular and therapeutic breakthroughs in Brain Tumors Sep 23 - Sep 26, 2023 Learn More Learn More Corporate Information Call of the ordinary and extraordinary shareholders’ meeting Jun 09, 2023 Genenta Corporate Deck June 2023 Jun 05, 2023 Financial Metrics Price Change Day High Day Low Volume Jun 8, 2023 7:21 AM EDT Stock Chart Data Provided by Refinitiv. Minimum 15 minutes delayed. Learn More
Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing Apr 26, 2023
Genenta Announces Extension of License Agreement with Ospedale San Raffaele to All Solid Tumor Indications Apr 03, 2023
EACR 2023 Congress, the Annual Congress of the European Association for Cancer Research Jun 14, 2023 Location Torino, Italy
POLIMI – Graduate School of Management live event “Paving the Way for a better Future: investing, nurturing, and growing Biotech and Sustainable companies Jun 22, 2023